Inhibition of CD200R1 Expression by C/EBP β in Reactive Microglial Cells
Overview
Authors
Affiliations
Background: In physiological conditions, it is postulated that neurons control microglial reactivity through a series of inhibitory mechanisms, involving either cell contact-dependent, soluble-factor-dependent or neurotransmitter-associated pathways. In the current study, we focus on CD200R1, a microglial receptor involved in one of these cell contact-dependent mechanisms. CD200R1 activation by its ligand, CD200 (mainly expressed by neurons in the central nervous system),is postulated to inhibit the pro-inflammatory phenotype of microglial cells, while alterations in CD200-CD200R1 signalling potentiate this phenotype. Little is known about the regulation of CD200R1 expression in microglia or possible alterations in the presence of pro-inflammatory stimuli.
Methods: Murine primary microglial cultures, mixed glial cultures from wild-type and CCAAT/enhancer binding protein β (C/EBPβ)-deficient mice, and the BV2 murine cell line overexpressing C/EBPβ were used to study the involvement of C/EBPβ transcription factor in the regulation of CD200R1 expression in response to a proinflammatory stimulus (lipopolysaccharide (LPS)). Binding of C/EBPβ to the CD200R1 promoter was determined by quantitative chromatin immunoprecipitation (qChIP). The involvement of histone deacetylase 1 in the control of CD200R1 expression by C/EBPβ was also determined by co-immunoprecipitation and qChIP.
Results: LPS treatment induced a decrease in CD200R1 mRNA and protein expression in microglial cells, an effect that was not observed in the absence of C/EBPβ. C/EBPβ overexpression in BV2 cells resulted in a decrease in basal CD200R1 mRNA and protein expression. In addition, C/EBPβ binding to the CD200R1 promoter was observed in LPS-treated but not in control glial cells, and also in control BV2 cells overexpressing C/EBPβ. Finally, we observed that histone deacetylase 1 co-immunoprecipitated with C/EBPβ and showed binding to a C/EBPβ consensus sequence of the CD200R1 promoter in LPS-treated glial cells. Moreover, histone deacetylase 1 inhibitors reversed the decrease in CD200R1 expression induced by LPS treatment.
Conclusions: CD200R1 expression decreases in microglial cells in the presence of a pro-inflammatory stimulus, an effect that is regulated, at least in part, by C/EBPβ. Histone deacetylase 1 may mediate C/EBPβ inhibition of CD200R1 expression, through a direct effect on C/EBPβ transcriptional activity and/or on chromatin structure.
The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson's disease.
Lin S, Shu Y, Shen R, Zhou Y, Pan H, He L J Neuroinflammation. 2024; 21(1):229.
PMID: 39294682 PMC: 11409543. DOI: 10.1186/s12974-024-03231-3.
C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease.
Yao Q, Long C, Yi P, Zhang G, Wan W, Rao X CNS Neurosci Ther. 2024; 30(4):e14721.
PMID: 38644578 PMC: 11033503. DOI: 10.1111/cns.14721.
Sierra-Magro A, Bartolome F, Lozano-Munoz D, Alarcon-Gil J, Gine E, Sanz-SanCristobal M Int J Mol Sci. 2023; 24(2).
PMID: 36674978 PMC: 9865173. DOI: 10.3390/ijms24021459.
Huang J, Zhang H, Guo X, Lu Y, Wang S, Cheng B Front Mol Biosci. 2021; 8:725275.
PMID: 34722630 PMC: 8548710. DOI: 10.3389/fmolb.2021.725275.
Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future.
Soares N, Vieira H Neurochem Res. 2021; 47(2):218-233.
PMID: 34586585 DOI: 10.1007/s11064-021-03456-1.